These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1419648)

  • 1. Sialyl Tn as a prognostic marker in epithelial ovarian cancer.
    Kobayashi H; Terao T; Kawashima Y
    Br J Cancer; 1992 Nov; 66(5):984-5. PubMed ID: 1419648
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum sialyl Tn as an independent predictor of poor prognosis in patients with epithelial ovarian cancer.
    Kobayashi H; Terao T; Kawashima Y
    J Clin Oncol; 1992 Jan; 10(1):95-101. PubMed ID: 1727929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tn and sialyl-Tn antigens as potential prognostic markers in human ovarian carcinoma.
    Ogawa H; Ghazizadeh M; Araki T
    Gynecol Obstet Invest; 1996; 41(4):278-83. PubMed ID: 8793500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A study of serum CASA and CA 125 levels in patients with ovarian carcinoma.
    Meisel M; Straube W; Weise J; Burkhardt B
    Arch Gynecol Obstet; 1995; 256(1):9-15. PubMed ID: 7726659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative determination of several serum tumor markers in patients with primary epithelial ovarian carcinoma.
    Kudoh K; Kikuchi Y; Kita T; Tode T; Takano M; Hirata J; Mano Y; Yamamoto K; Nagata I
    Gynecol Obstet Invest; 1999; 47(1):52-7. PubMed ID: 9852392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [CA-12 tumor marker values in serum following radioimmuno-scintigraphy].
    Barrada M; Pateisky N; Schatten C; Philipp K; Sevelda P; Vavra N
    Gynakol Rundsch; 1990; 30 Suppl 1():72-3. PubMed ID: 2079306
    [No Abstract]   [Full Text] [Related]  

  • 7. [Basic and clinical evaluation of an immunoradiometric competitive inhibition assay for sialyl TN antigen: (2). Evaluation of clinical significance. STN Study Group].
    Imura H; Mori T; Ohkura H; Ishii M; Ariyoshi H; Endo J; Kitao M; Takeda I; Kobayashi H; Inoue M
    Gan To Kagaku Ryoho; 1989 Sep; 16(9):3221-30. PubMed ID: 2571323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical evaluation of circulating serum sialyl Tn antigen levels in patients with epithelial ovarian cancer.
    Kobayashi H; Terao T; Kawashima Y
    J Clin Oncol; 1991 Jun; 9(6):983-7. PubMed ID: 1851822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between breast cancer mucin (BCM) and CA 125 serum levels in patients with active ovarian tumors.
    Roiz C; Allende T; Fernández-García J; Vivanco J; Bianco A; Ruibal A
    Int J Biol Markers; 1990; 5(4):207. PubMed ID: 2093735
    [No Abstract]   [Full Text] [Related]  

  • 10. Prechemotherapy serum CA125 level as a predictor of survival outcome in epithelial carcinoma of the ovary.
    Davidson NG; Khanna S; Kirwan PH; Bircumshaw D
    Clin Oncol (R Coll Radiol); 1991 Jan; 3(1):32-6. PubMed ID: 2001340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Circulating serum STN antigen as a prognostic marker in epithelial ovarian cancer].
    Kobayashi H; Terao T; Kawashima Y
    Gan To Kagaku Ryoho; 1991 Aug; 18(10):1651-5. PubMed ID: 1678592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of CA 125 in advanced ovarian cancer.
    Malkasian GD
    Gynecol Oncol; 1992 Mar; 44(3):205-6. PubMed ID: 1541429
    [No Abstract]   [Full Text] [Related]  

  • 13. A prospective study of tumor markers CA 125 and CA 19.9 in patients with epithelial ovarian carcinomas.
    Molina R; Ojeda B; Filella X; Borras G; Jo J; Mas E; Lopez JJ; Ballesta A
    Tumour Biol; 1992; 13(5-6):278-86. PubMed ID: 1290025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative studies of the prognostic relevance of tumor markers in ovarian cancer].
    Dörffler P; Caffier H
    Gynakol Geburtshilfliche Rundsch; 1993; 33 Suppl 1():293-5. PubMed ID: 8118321
    [No Abstract]   [Full Text] [Related]  

  • 15. Screening for ovarian cancer. Multiple markers may outperform CA 125 alone.
    Bast R; Woolas R
    BMJ; 1993 Jun; 306(6893):1684-5. PubMed ID: 8324445
    [No Abstract]   [Full Text] [Related]  

  • 16. Monitoring CA 125 serum levels during early chemotherapy is an excellent prognostic method in advanced ovarian cancer.
    Högberg T; Kågedal B
    Gynecol Oncol; 1993 Mar; 48(3):413-4. PubMed ID: 8462909
    [No Abstract]   [Full Text] [Related]  

  • 17. Soluble IL-2 alpha and ovarian cancer.
    Barton DP
    Br J Cancer; 1994 Mar; 69(3):622-3. PubMed ID: 8123502
    [No Abstract]   [Full Text] [Related]  

  • 18. Expression of Tn and sialyl-Tn antigens in tumor tissues of the ovary.
    Inoue M; Ton SM; Ogawa H; Tanizawa O
    Am J Clin Pathol; 1991 Dec; 96(6):711-6. PubMed ID: 1720922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Report of BACR workshop on monoclonal antibodies in breast and ovarian cancer, Brasenose College, Oxford March 17-19th 1991.
    Leonard RC; Fisken J; Roulston JE
    Br J Cancer; 1991 Oct; 64(4):796-7. PubMed ID: 1911231
    [No Abstract]   [Full Text] [Related]  

  • 20. [CA125 and radioimmunoimaging in monitoring of epithelial ovarian carcinoma].
    Yu Q; Lian LJ
    Zhonghua Fu Chan Ke Za Zhi; 1991 Jul; 26(4):235-8, 252. PubMed ID: 1914661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.